If 340B did not exist, drug companies would have an extra $6 billion in their pocket.
Elizabeth Warren: “If 340B did not exist, drug companies would have an extra $6 billion in their pocket.”
On the recordMarch 14, 2018
Source
congress.govEditor's note · Context
Warren argues that the 340B Program's discounts are minimal compared to drug companies' profits.
Share
More from Elizabeth Warren
Oct 17, 2026
Barclays continues to dodge responsibility over its apparent failure to vet its former CEO Jes Staley’s close professional and personal ties to Epstein.
Oct 17, 2026
I have spent the last year calling on Donald Trump’s financial regulators to launch investigations into the big banks and executives who may have enabled Jeffrey Epstein’s horrific crimes.
Oct 14, 2026
At the same time that it is refusing to invest in workers at its existing facilities in New England, the company is pouring money into its new ventures, including a casino in the United Arab Emirates.





